These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 27056241)
21. PD-1 Blockade in Melanoma: A Promising Start, but a Long Way to Go. Bhatia S; Thompson JA JAMA; 2016 Apr; 315(15):1573-5. PubMed ID: 27092829 [No Abstract] [Full Text] [Related]
22. Severe bullous pemphigoid associated with pembrolizumab therapy for metastatic melanoma with complete regression. Rofe O; Bar-Sela G; Keidar Z; Sezin T; Sadik CD; Bergman R Clin Exp Dermatol; 2017 Apr; 42(3):309-312. PubMed ID: 28211077 [TBL] [Abstract][Full Text] [Related]
23. The place of PD-1 inhibitors in melanoma management. Bowyer S; Lorigan P Lancet Oncol; 2015 Aug; 16(8):873-4. PubMed ID: 26115798 [No Abstract] [Full Text] [Related]
25. The safety of anti PD-1 therapeutics for the treatment of melanoma. Ramelyte E; Schindler SA; Dummer R Expert Opin Drug Saf; 2017 Jan; 16(1):41-53. PubMed ID: 27737598 [TBL] [Abstract][Full Text] [Related]
26. Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse. Lomax AJ; Beith J; Bhadri V; Boyer M; Grimison P; Horvath LG; Kao S; Tattersall M; Thomas D; McNeil C Intern Med J; 2016 Dec; 46(12):1392-1398. PubMed ID: 27554283 [TBL] [Abstract][Full Text] [Related]
27. [Autoimmune endocrinopathies induced by immunomodulating antibodies in the treatment of cancer]. Iglesias P; Soria A; Díez JJ Med Clin (Barc); 2015 Sep; 145(6):264-8. PubMed ID: 25851909 [No Abstract] [Full Text] [Related]
34. A case of arthritis under pembrolizumab. Salmon JH; Lambrecht I; Brochot P; Grange F Joint Bone Spine; 2017 Mar; 84(2):243-244. PubMed ID: 27118015 [No Abstract] [Full Text] [Related]
35. The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis. Puri A; Homsi J Melanoma Res; 2017 Oct; 27(5):519-523. PubMed ID: 28817445 [TBL] [Abstract][Full Text] [Related]
36. Setting the bar for adjuvant treatment of melanoma. Sondak VK; Gibney GT Lancet Oncol; 2014 May; 15(6):547-8. PubMed ID: 24745697 [No Abstract] [Full Text] [Related]
37. Pembrolizumab superior to ipilimumab in melanoma. Cancer Discov; 2015 Jun; 5(6):568. PubMed ID: 25895921 [TBL] [Abstract][Full Text] [Related]